Although chronic sinusitis widely affects the adult population, the treatments currently used did not always satisfactorily solve the symptoms. Traditional therapy with steroids and antibiotics presents risks and benefits and the new drugs, i.e., monoclonal antibody, are valid solutions despite being quite expensive. Natural molecules could be a valid treatment that combines good efficacy and low price. We conducted a case -control study to evaluate the benefit of an oral supplement with Ribes nigrum, Boswellia serrata, Bromelain and Vitamin D on chronic sinusitis symptoms. 60 patients were randomly assigned to one of the three groups: control using nasal steroids only, treatment 1 using nasal steroid and 1 dose of the oral supplement for 30 days and treatment 2 in which patients used nasal steroid and two oral supplement doses daily for 15 days. Conditions of the nasal mucosa and a blood sample (WBC, IgE and CRP) were analyzed at T0, T1 (15 days after treatment) and T2 (30 days after treatment. Patients treated with the supplement improved their nasal findings (hyperemia of mucosa and rhinorrhea) with statistically significant differences from the control. Our preliminary data suggest that the addition of supplement containing Ribes nigrum, Boswellia serrata, Vitamin D and Bromelain to the traditional local therapy (nasal spray with cortisone) can be a supporting therapy to modulate the local inflammation in the nose in patients affected by chronic sinusitis.

A supplement with ribes nigrum, boswellia serrata, bromelain and vitamin D to stop local inflammation in chronic sinusitis: a case-control study / DE LUCA, Pietro; D’Ascanio, Luca; Cingolani, Cristina; Latini, Gino; Grigaliute, Egle; Di Mauro, Paola; Ralli, Massimo; La Mantia, Ignazio; DI STADIO, Arianna. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 12:8(2023). [10.3390/jcm12082929]

A supplement with ribes nigrum, boswellia serrata, bromelain and vitamin D to stop local inflammation in chronic sinusitis: a case-control study

Pietro De Luca
Primo
Validation
;
Massimo Ralli
Writing – Original Draft Preparation
;
Arianna Di Stadio
Ultimo
Conceptualization
2023

Abstract

Although chronic sinusitis widely affects the adult population, the treatments currently used did not always satisfactorily solve the symptoms. Traditional therapy with steroids and antibiotics presents risks and benefits and the new drugs, i.e., monoclonal antibody, are valid solutions despite being quite expensive. Natural molecules could be a valid treatment that combines good efficacy and low price. We conducted a case -control study to evaluate the benefit of an oral supplement with Ribes nigrum, Boswellia serrata, Bromelain and Vitamin D on chronic sinusitis symptoms. 60 patients were randomly assigned to one of the three groups: control using nasal steroids only, treatment 1 using nasal steroid and 1 dose of the oral supplement for 30 days and treatment 2 in which patients used nasal steroid and two oral supplement doses daily for 15 days. Conditions of the nasal mucosa and a blood sample (WBC, IgE and CRP) were analyzed at T0, T1 (15 days after treatment) and T2 (30 days after treatment. Patients treated with the supplement improved their nasal findings (hyperemia of mucosa and rhinorrhea) with statistically significant differences from the control. Our preliminary data suggest that the addition of supplement containing Ribes nigrum, Boswellia serrata, Vitamin D and Bromelain to the traditional local therapy (nasal spray with cortisone) can be a supporting therapy to modulate the local inflammation in the nose in patients affected by chronic sinusitis.
2023
boswellia; vitamin D; chronic sinusitis; nasal hyperemia; rhinorrhea; treatment
01 Pubblicazione su rivista::01a Articolo in rivista
A supplement with ribes nigrum, boswellia serrata, bromelain and vitamin D to stop local inflammation in chronic sinusitis: a case-control study / DE LUCA, Pietro; D’Ascanio, Luca; Cingolani, Cristina; Latini, Gino; Grigaliute, Egle; Di Mauro, Paola; Ralli, Massimo; La Mantia, Ignazio; DI STADIO, Arianna. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 12:8(2023). [10.3390/jcm12082929]
File allegati a questo prodotto
File Dimensione Formato  
De Luca_A Supplement with_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.66 MB
Formato Adobe PDF
1.66 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1695665
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact